A retrospective study of rate of patients progressing to onabotulinumtoxinA as a third line OAB treatment and continuing treatment with and without a treatment navigator
Latest Information Update: 06 Dec 2021
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 06 Dec 2021 New trial record
- 17 Oct 2021 Results presented at the 51st Annual Meeting of the International Continence Society